Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1988 | 1 |
1990 | 2 |
1993 | 1 |
1995 | 1 |
1998 | 2 |
1999 | 1 |
2000 | 2 |
2001 | 1 |
2002 | 1 |
2003 | 2 |
2004 | 2 |
2005 | 7 |
2006 | 3 |
2007 | 5 |
2008 | 11 |
2009 | 9 |
2010 | 10 |
2011 | 11 |
2012 | 13 |
2013 | 18 |
2014 | 24 |
2015 | 26 |
2016 | 26 |
2017 | 21 |
2018 | 28 |
2019 | 28 |
2020 | 31 |
2021 | 37 |
2022 | 31 |
2023 | 25 |
2024 | 12 |
Search Results
331 results
Results by year
Abemaciclib plus fulvestrant significantly extended PFS versus fulvestrant alone (median, 16.4 v 9.3 months; hazard ratio, 0.553; 95% CI, 0.449 to 0.681; P < .001). In patients with measurable disease, abemaciclib plus fulvestrant achieved an ORR of 48.1% (95% CI, 42.6%
…We identified 65 new loci that are associated with overall breast cancer risk at P < 5 10(-8). The majority of credible risk single-nucleotide polymorphisms in these loci fall in distal regulatory elements, and by integrating in silico data to predict target genes in br
…We identified 65 new loci that are associated with overall breast cancer risk at P < 5 10(-8). The majority of credible risk singl
…